(±)20-HDHA

• UNSPSC Description:

  (±)20-HDHA ((±)20-HDoHE) is a racemic mixture and is an autoxidation product of Docosahexaenoic acid (DHA). (±)20-HDHA is also formed by peroxidation process in human platelets and rat brain homogenate[1][2][3].

• Target Antigen:

  Endogenous Metabolite

• Type:

  Natural Products

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Neuroscience-Neurodegeneration

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/racemic-20-hdha.html

• Purity:

  97.0

• Solubility:

  10 mM in DMSO

• Smiles:

  CCC(O)/C=C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(O)=O

• Molecular Weight:

  344.49

• References & Citations:

  [1]VanRollins M, et al. Autooxidation of docosahexaenoic acid: analysis of ten isomers of hydroxydocosahexaenoate. J Lipid Res. 1984 May;25(5):507-17.|[2]Kim HY, et al. Stereochemical analysis of hydroxylated docosahexaenoates produced by human platelets and rat brain homogenate. Prostaglandins. 1990 Nov;40(5):473-90.|[3]Hong S, et al. Resolvin D1, protectin D1, and related docosahexaenoic acid-derived products: Analysis via electrospray/low energy tandem mass spectrometry based on spectra and fragmentation mechanisms. J Am Soc Mass Spectrom. 2007 Jan;18(1):128-44.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  Solution, -20°C, 2 years

• Clinical Information:

  No Development Reported

• CAS Number:

  90906-41-5